TuHURA Biosciences, Inc. ("TuHURA"), a Phase 3 immune-oncology company developing novel technologies to overcome resistance to cancer immunotherapy, today provided updates across the company's ...
The Tableau Services Market is expanding as organizations adopt advanced analytics, AI-powered insights, and cloud-based BI solutions, with the U.S. segment rising from USD 0.82 billion in 2025 to USD ...
OptiPrime, parent brand of OptiSigns — a B2B SaaS focused on digital signage trusted by over 36,000 companies — today announced the launch of OptiDev (optidev.ai), a new AI-first application building ...
Nielsen, a global leader in audience measurement, data and analytics, is sharing a new “Tops of Sports” report on the major ...
The microscopic organisms that fill our bodies, soils, oceans and atmosphere play essential roles in human health and the ...
Sacituzumab govitecan and pembrolizumab showed a manageable safety profile in PD-L1–positive metastatic TNBC, with lower dose reduction or discontinuation rates than chemotherapy. The combination ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback